|
1
|
Qu HQ, Zhou XS, Zhou XL and Wang J: Effect
of DC-CIK cell on the proliferation, apoptosis and differentiation
of leukemia cells. Asian Pac J Trop Med. 7:659–662. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schmeel FC, Schmeel LC, Gast SM and
Schmidt-Wolf IG: Adoptive immunotherapy strategies with
cytokine-induced killer (CIK) cells in the treatment of
hematological malignancies. Int J Mol Sci. 15:14632–14648. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wefers C, Lambert LJ, Torensma R and Hato
SV: Cellular immunotherapy in ovarian cancer: Targeting the stem of
recurrence. Gynecol Oncol. 137:335–342. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wongkajornsilp A, Wamanuttajinda V,
Kasetsinsombat K, Duangsa-ard S, Sa-ngiamsuntorn K, Hongeng S and
Maneechotesuwan K: Sunitinib indirectly enhanced anti-tumor
cytotoxicity of cytokine-induced killer cells and
CD3+CD56+ subset through the co-culturing
dendritic cells. PLoS One. 8:e789802013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Introna M, Golay J and Rambaldi A:
Cytokine induced killer (CIK) cells for the treatment of
haematological neoplasms. Immunol Lett. 155:27–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Banchereau J and Palucka AK: Dendritic
cells as therapeutic vaccines against cancer. Nat Rev Immunol.
5:296–306. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thorne SH, Negrin RS and Contag CH:
Synergistic antitumor effects of immune cell-viral biotherapy.
Science. 311:1780–1784. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thurner B, Haendle I, Röder C, Dieckmann
D, Keikavoussi P, Jonuleit H, Bender A, Maczek C, Schreiner D, von
den Driesch P, et al: Vaccination with mage-3A1 peptide-pulsed
mature, monocyte-derived dendritic cells expands specific cytotoxic
T cells and induces regression of some metastases in advanced stage
IV melanoma. J Exp Med. 190:1669–1678. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nestle FO, Alijagic S, Gilliet M, Sun Y,
Grabbe S, Dummer R, Burg G and Schadendorf D: Vaccination of
melanoma patients with peptide- or tumor lysate-pulsed dendritic
cells. Nat Med. 4:328–332. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mody N, Dubey S, Sharma R, Agrawal U and
Vyas SP: Dendritic cell-based vaccine research against cancer.
Expert Rev Clin Immunol. 11:213–232. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Frank MO, Kaufman J, Parveen S, Blachère
NE, Orange DE and Darnell RB: Dendritic cell vaccines containing
lymphocytes produce improved immunogenicity in patients with
cancer. J Transl Med. 12:3382014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu H, Yang X, Li J, Ren Y, Zhang T, Zhang
C, Zhang J, Li J and Pang Y: Immune response, safety and survival
and quality of life outcomes for advanced colorectal cancer
patients treated with dendritic cell vaccine and cytokine-induced
killer cell therapy. Biomed Res Int. 2014:6038712014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pan K, Li YQ, Wang W, Xu L, Zhang YJ,
Zheng HX, Zhao JJ, Qiu HJ, Weng DS, Li JJ, et al: The efficacy of
cytokine-induced killer cell infusion as an adjuvant therapy for
postoperative hepatocellular carcinoma patients. Ann Surg Oncol.
20:4305–4311. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Laport GG, Sheehan K, Baker J, Armstrong
R, Wong RM, Lowsky R, Johnston LJ, Shizuru JA, Miklos D, Arai S, et
al: Adoptive immunotherapy with cytokine-induced killer cells for
patients with relapsed hematologic malignancies after allogeneic
hematopoietic cell transplantation. Biol Blood Marrow Transplant.
17:1679–1687. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miao L, Run-Ming J and Yi J: T-Bet
mediated anti-neoplastic effects of dendritic cell-cytokine induced
killer cells in vitro. Iran J Pediatr. 22:43–51. 2012.PubMed/NCBI
|
|
16
|
Pan Y, Tao Q, Wang H, Xiong S, Zhang R,
Chen T, Tao L and Zhai Z: Dendritic cells decreased the concomitant
expanded Tregs and Tregs related IL-35 in cytokine-induced killer
cells and increased their cytotoxicity against leukemia cells. PLoS
One. 9:e935912014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lenahan C and Avigan D: Dendritic cell
defects in patients with cancer: mechanisms and significance.
Breast Cancer Res. 8:1012006. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen J, Wei Y, He J, Cui G, Zhu Y, Lu C,
Ding Y, Xue R, Bai L, Uede T, et al: Natural killer T cells play a
necessary role in modulating of immune-mediated liver injury by gut
microbiota. Sci Rep. 4:72592014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Datta J, Terhune JH, Lowenfeld L, Cintolo
JA, Xu S, Roses RE and Czerniecki BJ: Optimizing dendritic
cell-based approaches for cancer immunotherapy. Yale J Biol Med.
87:491–518. 2014.PubMed/NCBI
|
|
20
|
Gütgemann S, Frank S, Strehl J and
Schmidt-Wolf IG: Cytokine-induced killer cells are type II natural
killer T cells. Ger Med Sci. 5:Doc072007.PubMed/NCBI
|
|
21
|
Margolin KA, Negrin RS, Wong KK,
Chatterjee S, Wright C and Forman SJ: Cellular immunotherapy and
autologous transplantation for hematologic malignancy. Immunol Rev.
157:231–240. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Linn YC and Hui KM: Cytokine-induced
killer cells: NK-like T cells with cytotolytic specificity against
leukemia. Leuk Lymphoma. 44:1457–1462. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hontscha C, Borck Y, Zhou H, Messmer D and
Schmidt-Wolf IG: Clinical trials on CIK cells: first report of the
international registry on CIK cells (IRCC). J Cancer Res Clin
Oncol. 137:305–310. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jäkel CE, Vogt A, Gonzalez-Carmona MA and
Schmidt-Wolf IG: Clinical studies applying cytokine-induced killer
cells for the treatment of gastrointestinal tumors. J Immunol Res.
2014:8972142014.PubMed/NCBI
|
|
25
|
Zhang Y, Xia L, Zhang Y, Wang Y, Lu X, Shi
F, Liu Y, Chen M, Feng K, Zhang W, et al: Analysis of adverse
events following the treatment of autologous cytokine-induced
killer cells for adoptive immunotherapy in malignant tumour
sufferers. Expert Opin Biol Ther. 15:481–493. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Q, Liu XY, Zhang T, Zhang XF, Zhao
L, Long F, Liu ZK and Wang EH: The dual-functional capability of
cytokine-induced killer cells and application in tumor immunology.
Hum Immunol. 76:385–391. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bach M, Schimmelpfennig C and Stolzing A:
Influence of murine mesenchymal stem cells on proliferation,
phenotype, vitality, and cytotoxicity of murine cytokine-induced
killer cells in coculture. PLoS One. 9:e881152014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chan WC and Linn YC: A comparison between
cytokine- and bead-stimulated polyclonal T cells: the superiority
of each and their possible complementary role. Cytotechnology. Dec
7–2014.(Epub ahead of print). PubMed/NCBI
|
|
29
|
Wang M, Cao JX, Pan JH, Liu YS, Xu BL, Li
D, Zhang XY, Li JL, Liu JL, Wang HB and Wang ZX: Adoptive
immunotherapy of cytokine-induced killer cell therapy in the
treatment of non-small cell lung cancer. PLoS One. 9:e1126622014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Salaun B, Yamamoto T, Badran B,
Tsunetsugu-Yokota Y, Roux A, Baitsch L, Rouas R, Fayyad-Kazan H,
Baumgaertner P, Devevre E, et al: Differentiation associated
regulation of microRNA expression in vivo in human CD8+
T cell subsets. J Transl Med. 9:442011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schmeel LC, Schmeel FC, Coch C and
Schmidt-Wolf IG: Cytokine-induced killer (CIK) cells in cancer
immunotherapy: report of the international registry on CIK cells
(IRCC). J Cancer Res Clin Oncol. 141:839–849. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xue CM, Chen C, Xu J, et al: Influence of
some traditional Chinese medicines (TCMS) on cytokine-induced
killer cells proliferation and anti-tumor features in vitro. Int J
Res Ayurveda Pharm. 4:228–232. 2013. View Article : Google Scholar
|
